A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia. - Manda S; Anz BM 3rd; Benton C; Broun ER; Yimer HA; Renshaw JS; Geils G Jr; Berdeja J; Cruz J; Melear JM; Fanning S; Fletcher L; et al. (Hematological oncology, 2024)